A phase I/II trial of WT1-specific TCR gene therapy for patients with acute myeloid leukemia and active disease post-allogeneic hematopoietic cell transplantation: skewing towards NK-like phenotype impairs T cell function and persistence

Relapsed and/or refractory acute myeloid leukemia (AML) post-allogeneic hematopoietic cell transplantation (HCT) is usually fatal. We previously reported that post-HCT immunotherapy with Epstein-Barr virus (EBV)-specific donor CD8 + T cells engineered to express a Wilms Tumor Antigen 1-specific T-ce...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature communications Jg. 16; H. 1; S. 5214 - 20
Hauptverfasser: Mazziotta, Francesco, Martin, Lauren E., Egan, Daniel N., Bar, Merav, Kinsella, Sinéad, Paulson, Kelly G., Voillet, Valentin, Lahman, Miranda C., Hunter, Daniel, Schmitt, Thomas M., Duerkopp, Natalie, Yeung, Cecilia C. S., Tang, Tzu-Hao, Gottardo, Raphael, Asano, Yuta, Wilcox, Elise C., Lee, Bo, Zhang, Tianzi, Lopedote, Paolo, Penter, Livius, Wu, Catherine J., Milano, Filippo, Greenberg, Philip D., Chapuis, Aude G.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: London Nature Publishing Group UK 05.06.2025
Nature Publishing Group
Nature Portfolio
Schlagworte:
ISSN:2041-1723, 2041-1723
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!